510
Participants
Start Date
November 10, 2015
Primary Completion Date
April 30, 2027
Study Completion Date
August 31, 2027
On-X Aortic Heart Valve replacement
Aortic valve replacement with low dose warfarin
Sentara Norfolk General Hospital, Norfolk
Carilion Clinic, Roanoke
Cleveland Clinic, Cleveland
The Lindner Center at The Christ Hospital, Cincinnati
Franciscan St. Francis, Indianapolis
Sanford Medical Center, Fargo
Baylor Scott & White - Plano, Plano
University of Texas Southwestern, Dallas
University of Texas Health Science Center - Houston, Houston
Arizona Cardiothoracic & Neurology, Tucson
Providence St. Vincent, Portland
Swedish Medical Center, Seattle
MultiCare Health System, Tacoma
Hartford Hospital, Hartford
Maine Medical Center, Portland
University of Calgary, Calgary
Victoria Heart Institute, Victoria
Blackpool Victoria Hospital, Blackpool
Hull & East Yorkshire Hospitals, Hull
John Radcliffe Hospital, Oxford
University of Ottawa Heart Institute, Ottawa
St. Bartholomew's Hospital, London
University Hospital Southampton, Southampton
Lead Sponsor
North American Science Associates Inc.
UNKNOWN
On-X Life Technologies, Inc.
INDUSTRY